Case Control Study
Copyright ©The Author(s) 2024.
World J Hepatol. Mar 27, 2024; 16(3): 366-378
Published online Mar 27, 2024. doi: 10.4254/wjh.v16.i3.366
Table 5 Association between genetic polymorphism and Lipid profile
Genetic polymorphismsLipid parameters
Triglyceride (mg/dL), (n = 177)
Total cholesterol (mg/dL), (n = 177)
LDL-cholesterol (mg/dL), (n = 177)
HDL-cholesterol (mg/dL), (n = 66)
HDL-cholesterol (mg/dL), (n = 111)

< 150
≥ 150
< 200
≥ 200
< 130
≥ 130
Men ≥ 40 mg/dL, women ≥ 50 mg/dL
Men < 40 mg/dL, women < 50 mg/dL
PNPLA3 rs738409 CC vs CG+GG
OR (95%CI)0.699 (0.383-1.277)1.053 (0.580-1.912)1.088 (0.597-1.981)0.9967 (0.538 -1.846)
P value0.2430.8650.7840.992
APOC3 rs2854116 TT vs CT+CC
OR (95%CI)0.796 (0.387-1.635)1.611 (0.780-3.328)1.173 (0.568-2.423)0.4696 (0.253-0.873)
P value0.5340.1950.6660.017a
APOA5 rs662799 AA vs AG+GG
OR (95%CI)1.021 (0.562-1.855)0.543 (0.299-0.989)0.595 (0.326-1.084)0.739 (0.374-1.461)
P value0.9460.045a0.0890.385
APOB rs10495712 (GG vs AG+AA)
OR (95%CI)0.749 (0.322-1.743)0.719 (0.315-1.639)0.807 (0.351-1.855)0.816 (0.343-1.938)
P value0.5010.4310.6130.645
LIPC rs1800588 CC vs CT+TT
OR (95%CI)0.870 (0.467-1.621)0.732 (0.393-1.363)0.607 (0.326-1.132)0.911 (0.482-1.722)
P value0.6610.3250.1150.774
LEP rs7799039 GG vs AG+AA
OR (95%CI)9.316 (2.064-40.428)1.623 (0.655-4.017)1.518 (0.602-3.825)1.317 (0.507-3.419)
P value0.001a0.2920.3740.572
GHRL rs27647 (AA vs AG+GG)
OR (95%CI)0.570 (0.265-1.224)0.997 (0.483-2.058)0.905 (0.436-1.878)0.889 (0.417-1.895)
P value0.1470.9930.7880.761